M. Sittig

发表

The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer.

C. Nieroda, A. Sardi, V. Gushchin, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

C. Nieroda, A. Sardi, V. Gushchin, 2020, Annals of Surgical Oncology.

Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.

N. Aydin, C. Nieroda, A. Sardi, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

C. Nieroda, A. Sardi, V. Gushchin, 2016, Annals of Surgical Oncology.

Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.

C. Nieroda, A. Sardi, Carlos A. Munoz-Zuluaga, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Port-Site Metastases is an Independent Prognostic Factor in Patients with Peritoneal Carcinomatosis

N. Aydin, C. Nieroda, A. Sardi, 2015, Annals of Surgical Oncology.

Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Experience of a Peritoneal Surface Malignancy Center

N. Aydin, C. Nieroda, A. Sardi, 2015, The American surgeon.

ASO Author Reflections: The Frailty of Patient Selection

T. Diaz-Montes, A. Sardi, M. Sittig, 2021, Annals of Surgical Oncology.

Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

C. Nieroda, A. Sardi, Carlos A. Munoz-Zuluaga, 2019, Annals of Surgical Oncology.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

C. Nieroda, A. Sardi, V. Gushchin, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of primary peritoneal carcinoma

C. Nieroda, T. Diaz-Montes, A. Sardi, 2017 .

Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC

C. Nieroda, A. Sardi, Carlos A. Munoz-Zuluaga, 2019, Annals of Surgical Oncology.

Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

C. Nieroda, A. Sardi, Carlos A. Munoz-Zuluaga, 2018, Annals of Surgical Oncology.

Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).

N. Aydin, C. Nieroda, A. Sardi, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Predictive and Prognostic Survival Factors in Peritoneal Carcinomatosis from Appendiceal Cancer After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

N. Aydin, C. Nieroda, A. Sardi, 2014, Annals of Surgical Oncology.

Defining “Complete Cytoreduction” After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis

C. Nieroda, A. Sardi, Carlos A. Munoz-Zuluaga, 2020, Annals of Surgical Oncology.

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience

C. Nieroda, A. Sardi, V. Gushchin, 2021, Journal of surgical oncology.

Pre- and post-operative antibiotics in conjunction with cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) should be considered for pseudomyxoma peritonei (PMP) treatment.

J. Metcalf, T. McAvoy, D. Merrell, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix

N. Aydin, C. Nieroda, A. Sardi, 2017, Annals of Surgical Oncology.

Melphalan: A Promising Agent in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

C. Nieroda, A. Sardi, V. Gushchin, 2014, Annals of Surgical Oncology.

Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent

C. Nieroda, A. Sardi, V. Gushchin, 2018, International journal of surgical oncology.

Pyoderma Gangrenosum in a Patient with Advanced Rectal Cancer Treated with Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

A. Sardi, M. Sittig, C. Velez-Mejia, 2019, The American surgeon.

Germline and somatic genetic alterations in two first‐degree relatives with appendiceal low‐grade mucinous carcinoma peritonei

A. Sardi, Carlos A. Munoz-Zuluaga, V. Gushchin, 2020, Clinical case reports.

Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

C. Nieroda, T. Diaz-Montes, A. Sardi, 2020, International journal of surgical oncology.